Edgewise Therapeutics announces pricing of IPO
BOULDER -- Edgewise Therapeutics, Inc. (NASDAQ: EWTX) announced the pricing of its underwritten initial public offering of 11,000,000 shares of its common stock at a public offering price of $16... Read More
Monday March 29, 2021 0 comments
Edgewise Therapeutics appoints Michael Carruthers to be CFO
BOULDER -- Edgewise Therapeutics, a clinical-stage biopharmaceutical company developing small molecule therapies for musculoskeletal diseases, today announced the appointment of R. Michael... Read More
Monday October 19, 2020 0 comments
Edgewise Therapeutics closes $50M Series B financing round
BOULDER -- Edgewise Therapeutics, a pre-clinical company developing small molecule therapies for musculoskeletal diseases, announced closing of a $50 million Series B financing round. The... Read More
Monday September 23, 2019 0 comments
IN Sponsors
Browse
Entrepreneurial by Nature
